Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Predicting adjuvant radiation therapy benefit in cutaneous squamous cell carcinoma with the 40-gene expression profile

4 Sept 2024

Abstract excerpt

Aim: To independently confirm that the 40-gene expression profile (40-GEP) test can identify patients with high-risk cutaneous squamous cell carcinoma who are more or less likely to benefit from adjuvant radiation therapy (ART).Materials & methods: Primary cutaneous squamous cell carcinoma tumors from two academic centers received retrospective 40-GEP testing and were analyzed for 5-year metastasis-free survival...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer and Skin Lesions
Share to Cutaneous Melanoma Detection and Management
Share to Nonmelanoma Skin Cancer Studies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 39229801
DOI: 10.1080/14796694.2024.2390820

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Predicting adjuvant radiation therapy benefit in cutaneous squamous cell carcinoma with the 40-gene expression profilePMID 39229801Read ↗

Integrating the 40-Gene Expression Profile (40-GEP) Test Improves Metastatic Risk-Stratification Within Clinically Relevant Subgroups of High-Risk Cutaneous Squamous Cell Carcinoma (cSCC) PatientsSemantic proximity Read ↗

The Role of Gene Expression Profiling in Management of Cutaneous Squamous Cell Cancer: A ReviewSemantic proximity Read ↗

Analytical validity of DecisionDx-SCC, a gene expression profile test to identify risk of metastasis in cutaneous squamous cell carcinoma (SCC) patientsSemantic proximity Read ↗

Optimizing treatment approaches for patients with cutaneous melanoma by integrating clinical and pathologic features with the 31-gene expression profile testSemantic proximity Read ↗

Development and Validation of a Gene Profile Predicting Benefit of Postmastectomy Radiotherapy in Patients with High-Risk Breast Cancer: A Study of Gene Expression in the DBCG82bc CohortSemantic proximity Read ↗

Analytic validity of DecisionDx-Melanoma, a gene expression profile test for determining metastatic risk in melanoma patientsSemantic proximity Read ↗

Immune-based classification of HPV-associated oropharyngeal cancer with implications for biomarker-driven treatment de-intensificationSemantic proximity Read ↗

Guidance of Sentinel Lymph Node Biopsy Decisions In Patients With T1–T2 Melanoma Using Gene Expression ProfilingSemantic proximity Read ↗

Use of a prognostic gene expression profile test for T1 cutaneous melanoma: Will it help or harm patients?Semantic proximity Read ↗

Radioresistance of Human Cancers: Clinical Implications of Genetic Expression SignaturesSemantic proximity Read ↗

A Gene-Expression Predictor for Efficacy of Induction Chemotherapy in Locoregionally Advanced Nasopharyngeal CarcinomaSemantic proximity Read ↗

Tailoring cancer radiotherapy through genotyping, how close are we?Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.